Back to Results
First PageMeta Content
Proteins / Erlotinib / Cyclin-dependent kinase 2 / Cyclin / CDKN1B / Epidermal growth factor receptor / Tyrosine kinase / Proteomics / Protein kinase inhibitor / Biology / Cell biology / Cell cycle


Differential protein signatures in erlotinib-sensitive and resistant lung cancer cell lines in vitro and in vivo 1Deb 1Ying
Add to Reading List

Document Date: 2014-06-25 17:02:13

Open Document

File Size: 1,88 MB

Share Result on Facebook

City

Aptamer / Morrisville / Boulder / /

Company

1SomaLogic Inc. / Mol Pharma / Agilent / /

/

IndustryTerm

aptamer proteomic technology / Antigen processing / proteomic technology / /

MedicalCondition

NOD/SCID / tumor / erlotinib-sensitive and resistant lung cancer / human non-small-cell lung cancer / lung cancer / SOMAscan™ Proteomic Assay NOD/SCID / Cancer / tumors / disease / NSCLC / mouse xenograft tumors / breast cancer / /

Organization

Extracellular / National Institute of Health / /

Person

Alexander Kel / Nick Saccomano / /

ProvinceOrState

North Carolina / Colorado / /

PublishedMedium

PLoS ONE / /

Technology

Bioinformatics / aptamer proteomic technology / DNA Chip / drug development / apoptosis / /

URL

http /

SocialTag